BALAXI PHARMACEUTICALS (BALAXI) — Financial Results

📢 Key Event
Q1 FY27 revenue grew 14% YoY to ₹80.68 crore with PAT up 347% to ₹1.29 crore.

🔄 What Changed
Gross margin improved by 241 bps to 46.5% and PAT margin increased by 120 bps to 1.6%.

🔮 What's Next
Commercial production commenced at Hyderabad facility; expects further profitability improvement as operating leverage strengthens.

💡 Investor Takeaway
The company is transitioning to backward integration, which should enhance margins and growth potential in frontier markets.

Balaxi Pharmaceuticals reported consolidated revenue of ₹80.68 crore for Q1 FY27, a 14% YoY increase from ₹70.74 crore in Q1 FY26, driven by improved gross margins and profitability. Gross profit margin expanded by 241 basis points to 46.5%, and PAT rose 347% YoY to ₹1.29 crore. The company achieved a key milestone with commercial production at its first pharmaceutical formulation facility in Hyderabad, targeting backward integration in Latin America and Africa. Strategic expansion continues across frontier markets with new product registrations and geographic presence.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BALAXI ✨ Ask AI About This

About BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Healthcare · Pharmaceuticals · Listed on NSE

ROE: 1.1% ROCE: 3.6%

View full BALAXI stock details →

📡 Get AI alerts when BALAXI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BALAXI — Free

💡 Ask AI about this filing

"How will backward integration impact margins in Latin America?" "What is the revenue contribution from new product registrations?" "When will the Hyderabad facility reach full production capacity?"

Ask AI Free →

📊 More BALAXI filings

See all BALAXI filings →

🔥 Also filed on 6 August 2026

CHAMBLFERT Chambal Fertilizers & Chemicals Limited Financial Results SUMEETINDS Sumeet Industries Limited Financial Results VISAKAIND Visaka Industries Limited Corporate Action VISAKAIND Visaka Industries Limited Corporate Action SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results VSTL Vibhor Steel Tubes Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BALAXI files new disclosures

Track BALAXI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BALAXI — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd